// App-Quantinova.ai

TCT CONNECT-248 : Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Insights From a Network Meta-Analysis of Randomized Trials

Researchers

Presenter

  • Toshiki Kuno

Principal Investigators

  • Hiroki Ueyama

  • Hisato Takagi

  • John Fox

  • Sripal Bangalore

Medical Centers

  • New York University School of Medicine, New York, NY

  • Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, New York, USA

  • Mount Sinai Beth Israel, New York, NY

  • Shizuoka Medical Center, Department of Cardiovascular Surgery, Shizuoka, Japan

Locations

  • United States

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved